Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (31-40 of 611) with videos related to

Pageof 62
Sort By:
Journal of Neurochemistry|October 1, 1996
Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neuronsP P Michel, Y Agid
Neurology|December 1, 1980
Is the mesocortical dopaminergic system involved in Parkinson disease?F Javoy-Agid, Y Agid
Brain Research|December 4, 1992
The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic culturesP P Michel, Y Agid
Annals of the New York Academy of Sciences|January 1, 1991
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsyB Pillon, B Dubois, Y Agid
Neuro-Chirurgie|January 1, 1995
[Iatrogenic Creutzfedt-Jacob disease. What precautions are to be taken for the prevention of neurosurgical contamination?]T Billette de Villemeur, Y Agid
Neuroscience|January 1, 1978
Dopaminergic nerve endings in the neostriatum of the rat--1. Identification by intracerebral injections of 5-hydroxydopamineM Arluison, Y Agid, F Javoy
Neuroscience|January 1, 1978
Dopaminergic nerve endings in the neostriatum of the rat--2. Radioautographic study following local micro-injections of tritiated dopamineM Arluison, Y Agid, F Javoy
Advances in Neurology|January 1, 1983
Effect of a methionine-enkephalin analog in Huntington's diseaseY Agid, A Destee, A Lallemand
Brain Research|July 5, 1974
Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolismY Agid, F Javoy, J Glowimski
The Journal of Pharmacy and Pharmacology|September 1, 1975
Oxotremorine- and atropine-induced changes of dopamine metabolism in the rat striatumF Javoy, Y Agid, J Glowinski
Pageof 62

Showing results (31-40 of 611) with videos related to

Sort By:
Pageof 62
Journal of Neurochemistry|October 1, 1996
Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neuronsP P Michel, Y Agid
Neurology|December 1, 1980
Is the mesocortical dopaminergic system involved in Parkinson disease?F Javoy-Agid, Y Agid
Brain Research|December 4, 1992
The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic culturesP P Michel, Y Agid
Annals of the New York Academy of Sciences|January 1, 1991
Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsyB Pillon, B Dubois, Y Agid
Neuro-Chirurgie|January 1, 1995
[Iatrogenic Creutzfedt-Jacob disease. What precautions are to be taken for the prevention of neurosurgical contamination?]T Billette de Villemeur, Y Agid
Neuroscience|January 1, 1978
Dopaminergic nerve endings in the neostriatum of the rat--1. Identification by intracerebral injections of 5-hydroxydopamineM Arluison, Y Agid, F Javoy
Neuroscience|January 1, 1978
Dopaminergic nerve endings in the neostriatum of the rat--2. Radioautographic study following local micro-injections of tritiated dopamineM Arluison, Y Agid, F Javoy
Advances in Neurology|January 1, 1983
Effect of a methionine-enkephalin analog in Huntington's diseaseY Agid, A Destee, A Lallemand
Brain Research|July 5, 1974
Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolismY Agid, F Javoy, J Glowimski
The Journal of Pharmacy and Pharmacology|September 1, 1975
Oxotremorine- and atropine-induced changes of dopamine metabolism in the rat striatumF Javoy, Y Agid, J Glowinski
Pageof 62